This inventor holds 6 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents. Top assignees: Provectus Pharmatech, Inc, Uti Limited Partnership, The University of Tennessee Research Foundation. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
6 out of 26 
5 out of 139 
1 out of 787 
Years Active: 2022-2026
Title: Innovator Dominic Rodrigues: Pioneering Treatments for Hematologic Cancers
Introduction
Dominic Rodrigues, an accomplished inventor based in Knoxville, TN, has made significant strides in the field of oncology through his innovative patents. With a total of five patents to his name, his contributions focus primarily on treating hematologic cancers using advanced methodologies and compositions.
Latest Patents
Rodrigues' most recent patents include groundbreaking methods designed to combat hematologic, non-tumorous cancer cells. One notable patent describes a composition and method involving halogenated xanthene. This method outlines the administration of a therapeutically effective amount of halogenated xanthene, formulated as a pharmaceutically acceptable salt or C-C4 alkyl ester, to mammals suffering from certain types of cancer. This innovative approach aims to induce the death of these cancer cells over a specified period and may be used synergistically with other cancer cytotoxic agents. Additionally, Rodrigues has developed a method for oral treatment of leukemia, employing similar therapeutic techniques to enhance patient outcomes.
Career Highlights
Throughout his career, Dominic Rodrigues has worked with esteemed companies such as Provectus Pharmatech, Inc and Uti Limited Partnership. His tenure at these organizations has allowed him to apply his expertise in pharmaceuticals to develop effective cancer treatments, ultimately leading to his multiple patents.
Collaborations
Rodrigues has collaborated with notable professionals, including Aru Narendran and Eric A Wachter. Their combined efforts emphasize the importance of teamwork in innovation and the development of effective cancer therapies.
Conclusion
Dominic Rodrigues continues to be a pivotal figure in the landscape of cancer treatment innovation. His dedication to improving therapeutic methods for hematologic cancers showcases the vital role inventors play in advancing science and healthcare. With an impressive portfolio of patents and valuable collaborations, Rodrigues exemplifies the impactful contributions of inventors to medical research and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile